Xenomics Closes US$1.0 Million Financing
New York (ots/PRNewswire) - Xenomics, Inc. (the "Company") (OTC Bulletin Board: XNOM; FWB: XE7), source of next-generation medical DNA technologies, announced today the closing of a private placement totaling US$1.0 million, whose proceeds will help to fund the Company's efforts to develop advanced medical diagnostic tests for a range of diseases and genetic conditions, and to fund preparations toward product ...
mehr